Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir

Nefrologia (Engl Ed). 2023 Dec:43 Suppl 2:112-113. doi: 10.1016/j.nefroe.2022.07.008. Epub 2023 Jan 25.

Authors

Aya Nakaya¹, Morihiro Kondo², Eiji Ogura², Yuki Katayama², Eiko Yoshino², Kazuya Hozumi², Saori Tago², Yuko Teranishi², Yuki Minamibashi², Makiko Harada², Yuri Kawano², Yuka Arai², Mika Kobayashi², Airi Kouyama², Keno Yoshida², Shozo Shimizu², Kazuma Ogura², Katsuaki Iwashita²; BOH Covid-19 Team²

Affiliations

¹ Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu City, Shiga 520-0232, Japan. Electronic address: nakaya1016@yahoo.co.jp.
² Internal Medicine, Biwako Ohashi Hospital, 5-1-29 Mano, Otsu City, Shiga 520-0232, Japan.

No abstract available

Publication types

Letter

MeSH terms

Adenosine Monophosphate / analogs & derivatives*
Alanine / analogs & derivatives*
Alanine / therapeutic use
COVID-19 Drug Treatment
COVID-19*
Humans
Renal Dialysis

Substances

remdesivir
Alanine
Adenosine Monophosphate